Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.

doi:10.1507/endocrj.45.255

Back to search

Article

Relation between apolipoprotein e phenotype and the changes in lipids during tamoxifen treatment.

Endocrine journal - 1 Apr 1998

Hozumi Y, Kawano M, Saito T, Miyata M

Abstract excerpt

We recently reported three cases of severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery. In that report we showed that one of the three patients had apo E3/3 and another had E4/2 phenotype. There are few data about the relationship between apoprotein E phenotype,...

Topics

Aged
Apolipoproteins E
Breast Neoplasms
Chemotherapy, Adjuvant
Cholesterol
Female
Humans
Hypertriglyceridemia
Lipids
Middle Aged
Phenotype
Tamoxifen
Triglycerides

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.